Cantitate/Preț
Produs
Total produse
Vezi coșul
Lymphohaematopoietic Growth Factors in Cancer Therapy de Roland Mertelsmann

Lymphohaematopoietic Growth Factors in Cancer Therapy: ESO Monographs

Editat de Roland Mertelsmann
en Limba Engleză Paperback – 22 noi 2011
Recent experimental and clinical progress in the evaluation of cytokines in treatment concepts for cancer patients is the central theme of this book in the ESO Monographs series. The discussion revolves on the experimental basis as well as current clinical experience with the use of human recombinant cytokines. It gives the state of the art and, as such, puts into perspective potential areas of growth and future research.
Citește tot Restrânge

Din seria ESO Monographs

  • 5% Antiandrogens in Prostate Cancer: A Key to Tailored Endocrine Treatment
    Preț: 71152 lei
  • 5% Endocrine Therapy of Breast Cancer: Concepts and Strategies
    Preț: 71152 lei
  • 5% Malignant Lymphomas: Biology and Treatment: An Update
    Preț: 71865 lei
  • 5% The Medical Management of Prostate Cancer
    Preț: 71023 lei
  • 5% Interferons: Mechanisms of Action and Role in Cancer Therapy
    Preț: 70697 lei
  • 5% Endocrine Therapy of Breast Cancer III
    Preț: 70697 lei
  • 5% Lymphohaematopoietic Growth Factors in Cancer Therapy II
    Preț: 71188 lei
  • 5% Familial Cancer Control
    Preț: 71260 lei
  • 5% Breast Cancer Screening in Europe
    Preț: 71406 lei
  • 5% Prostate Cancer 2000
    Preț: 70951 lei
  • 5% Innovative Antimetabolites in Solid Tumours
    Preț: 70620 lei
  • 5% Biological Modulation of Solid Tumours by Interferons
    Preț: 70769 lei
  • 5% Current Topics in Lung Cancer
    Preț: 70841 lei
  • 5% Electropotentials in the Clinical Assessment of Breast Neoplasia
    Preț: 70769 lei
  • 5% The Medical Management of Prostate Cancer II
    Preț: 71023 lei
  • 5% Antiemetics in the Supportive Care of Cancer Patients
    Preț: 71406 lei
  • 5% Control of Growth Factors and Prevention of Cancer
    Preț: 70769 lei
  • 5% Neurological Adverse Reactions to Anticancer Drugs
    Preț: 108839 lei
  • 5% Retinoids in Oncology
    Preț: 108985 lei
  • 5% Psychosocial Aspects of Oncology
    Preț: 71370 lei
  • 5% Drug Delivery in Cancer Treatment II: Symptom Control, Cytokines, Chemotherapy
    Preț: 71079 lei
  • 5% Air Pollution and Human Cancer
    Preț: 108731 lei
  • 5% Diet and the Aetiology of Cancer
    Preț: 70769 lei
  • 5% Endocrine Therapy of Breast Cancer V
    Preț: 71006 lei
  • 5% New Approaches in Cancer Pharmacology: Drug Design and Development
    Preț: 36324 lei
  • 5% Endocrine Therapy of Breast Cancer IV
    Preț: 70987 lei
  • 5% Indoor and Outdoor Air Pollution and Human Cancer
    Preț: 71535 lei
  • 5% Endocrine Therapy of Breast Cancer VI
    Preț: 70987 lei
  • 5% Human Tumour Xenografts in Anticancer Drug Development
    Preț: 109408 lei
  • 5% Drug Delivery in Cancer Treatment III: Home Care — Symptom Control, Economy, Brain Tumours
    Preț: 71246 lei
  • 5% Management in Neuro-Oncology
    Preț: 71043 lei
  • 5% New Approaches to the Treatment of Leukemia
    Preț: 71829 lei
  • 5% The Role of Multiple Intensification in Medical Oncology
    Preț: 35960 lei
  • Magnetic Resonance in Oncology
    Preț: 38949 lei

Preț: 70914 lei

Preț vechi: 74647 lei
-5% Nou

Puncte Express: 1064
Preț estimativ în valută:
13570€ • 14510$ • 11314£

Carte tipărită la comandă

Livrare economică 17 aprilie-01 mai

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783642760396
ISBN-10: 3642760392
Pagini: 104
Ilustrații: VII, 92 p.
Dimensiuni: 210 x 279 x 5 mm
Greutate: 0.25 kg
Ediția:Softcover reprint of the original 1st ed. 1990
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria ESO Monographs

Locul publicării:Berlin, Heidelberg, Germany

Public țintă

Research

Cuprins

Interleukins and Haematopoietic Growth Factors.- Mechanisms of T-Cell Activation.- Characteristics of LAK Cells and their use in Adoptive Therapy of Cancer in Experimental Animals.- Interleukin 2: In Vivo Induction of Effector Cells.- Cellular Immunotherapy of Cancer: The use of Lymphokine-Activated Natural Killer (LANAK) Cells.- Interleukin 2: Clinical Aspects.- Interleukin 2 and LAK Cells.